Research.Patient.info

Chronic dialysis, Cardiovascular disease research hub

1 indexed studies · 0 currently recruiting

authorisedPhase III and phase IV (Integrated)
SCARP-DIAL (SGLT2i for CARdiovascular Protection in DIALysis)
The SCARP-DIAL study is testing a daily tablet called dapagliflozin in people receiving long-term dialysis. Researchers want to find out if this medication can help protect the heart and lower the risk of heart attacks, strokes, and emergency hospital visits for heart problems in people with kidney failure.
Sweden